Super Micro Computer, Inc. (NASDAQ:SMCI) just released its latest quarterly report and things are not looking great. It wasn't a great result overall - while revenue fell marginally short of analyst estimates at US$4.6b, statutory earnings missed forecasts by 13%, coming in at just …
Over the last 7 days, the United States market has risen by 5.1%, contributing to an impressive 11% climb over the past year, with earnings forecasted to grow by 14% annually. In this context of robust market performance, selecting dividend stocks like Sierra Bancorp …
Snail, Inc. SNAL reported first-quarter 2025 results, with earnings and revenues beating the Zacks Consensus Estimate. The top line increased year over year, while the bottom line declined from the prior-year quarter’s figure. Following the results, SNAL’s shares lost 2.5% in the after-hours trading …
Airlines are dialing back expectations as macro concerns and safety incidents weigh on summer travel, with several major airlines revising and even pulling their full-year outlooks. In fact, international spending in the US is expected to decline $12.5 billion this year. Third Bridge global …
Elon Musk and Tesla Inc (NASDAQ:TSLA) could have company soon with the launch of the Slate electric pickup truck, a new electric vehicle from a company backed by Amazon.com founder and Musk rival Jeff Bezos. If early demand is any indication, the Slate EV …
While Hexcel Corporation (NYSE:HXL) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 16% in the last quarter. But at least the stock is up over the last five years. In that time, it is …
Vancouver, BC, May 15, 2025 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”), is pleased to announce that its joint-venture partner, Orano Canada Inc. (“Orano”), will commence a large-scale diamond drilling program at the 49,635-hectare Preston …
- Received approval by U.S. Food and Drug Administration (FDA) for ZEVASKYN™ (prademagene zamikeracel), the first and only autologous cell-based gene therapy for the treatment of wounds in adult and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB) - - U.S. launch of ZEVASKYN …
LOUISVILLE, Ky., May 15, 2025 (GLOBE NEWSWIRE) -- Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage, media and AdTech solutions, today announced that it will participate in the Ladenburg Thalmann Innovation Expo 2025, at Convene, …
Cytokinetics, Incorporated Second Annual Muscle Biology-Focused Research Symposium Highlighting Recent Innovations in the Field SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the Company will host the second annual Contemporary Landscapes in Muscle Biology Research …